NanoVibronix, Inc. (NASDAQ:NAOV) Short Interest Down 58.0% in January

NanoVibronix, Inc. (NASDAQ:NAOV) was the target of a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 249,900 shares, a decline of 58.0% from the December 31st total of 594,600 shares. Currently, 6.7% of the company’s stock are sold short. Based on an average trading volume of 1,380,000 shares, the short-interest ratio is currently 0.2 days.

NanoVibronix Trading Down 11.0 %

Shares of NAOV stock traded down $0.07 during trading hours on Friday, reaching $0.53. 2,242,400 shares of the company’s stock were exchanged, compared to its average volume of 9,167,701. NanoVibronix has a 1 year low of $0.37 and a 1 year high of $1.52. The stock has a market cap of $1.97 million, a PE ratio of -0.43 and a beta of 1.64. The stock’s fifty day moving average price is $0.59 and its two-hundred day moving average price is $0.61.

NanoVibronix Company Profile

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.